Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 2, 2010, Pages 592-600

  Habib, Zeina A ^a   Havstad, Suzanne L ^a   Wells, Karen ^a   Divine, George ^a   Pladevall, Manel ^a,b   Williams, L Keoki ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CORTICOSTEROID; HEMOGLOBIN A1C; INSULIN; PIOGLITAZONE; ROSIGLITAZONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; FEMALE; FRACTURE; HUMAN; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 76149114236     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1385     Document Type: Article

References (46)

1. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A 2007 Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 22:465-475
2. Schubert C 2009 Bone seems susceptible to range of drugs. Nat Med 15:588
3. Ensrud KE, Walczak TS, Blackwell T, Ensrud ER, Bowman PJ, Stone KL 2004 Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology 62:2051-2057
4. Ensrud KE, Walczak TS, Blackwell TL, Ensrud ER, Barrett-Connor E, Orwoll ES 2008 Antiepileptic drug use and rates of hip bone loss in older men: a prospective study. Neurology 71:723-730
5. van den Brand MW, Samson MM, Pouwels S, van Staa TP, Thio B, Cooper C, Leufkens HG, Egberts AC, Verhaar HJ, de Vries F 2009 Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporos Int 20:1705-1713
6. Laine L 2009 Proton pump inhibitors and bone fractures? Am J Gastroenterol 104 Suppl 2:S21-S26
7. Schwartz AV, Sellmeyer DE, Vittinghoff E, Palermo L, Lecka-Czernik B, Feingold KR, Strotmeyer ES, Resnick HE, Carbone L, Beamer BA, Park SW, Lane NE, Harris TB, Cummings SR 2006 Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab 91:3349-3354
8. Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'NeillMC,Zinman B, Viberti G 2006 Glycemic durability of rosiglitazone, metformin, or glyburidemonotherapy. N Engl J Med 355:2427-2443
9. Meier C, Kraenzlin ME, Bodmer M, Jick SS, Jick H, Meier CR 2008 Use of thiazolidinediones and fracture risk. Arch Intern Med 168: 820-825
10. DormandyJ, BhattacharyaM,van Troostenburg de BruynAR2009 Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive. Drug Saf 32:187-202
11. Loke YK, Singh S, Furberg CD 2009 Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.CMAJ 180:32-39
12. Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ 2009 Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet 373:2125-2135
13. Yaturu S, Bryant B, Jain SK 2007 Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men. Diabetes Care 30:1574-1576
14. Yki-Järvinen H 2004 Thiazolidinediones.NEngl J Med 351:1106-1118
15. Schwartz AV, Sellmeyer DE, Strotmeyer ES, Tylavsky FA, Feingold KR, Resnick HE, Shorr RI, Nevitt MC, Black DM, Cauley JA, Cummings SR, Harris TB 2005 Diabetes and bone loss at the hip in older black and white adults. J Bone Miner Res 20:596-603
16. Leslie WD, Lix LM, Prior HJ, Derksen S, Metge C, O'Neil J 2007 Biphasic fracture risk in diabetes: a population-based study. Bone 40:1595-1601
17. Schwartz AV 2006 Diabetes, TZDs, and bone: a review of the clinical evidence. PPAR Res 2006:24502
18. Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, Johnson KC, Margolis KL 2006 Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J Clin Endocrinol Metab 91:3404-3410
19. Ivers RQ, Cumming RG, Mitchell P, Peduto AJ 2001 Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care 24: 1198-1203
20. Schwartz AV, Sellmeyer DE 2004 Women, type 2 diabetes, and fracture risk. Curr Diab Rep 4:364-369
21. Casellini CM, Vinik AI 2007 Clinical manifestations and current treatment options for diabetic neuropathies. Endocr Pract 13:550-566
22. Jørgensen L, Engstad T, Jacobsen BK 2002 Higher incidence of falls in long-term stroke survivors than in population controls: depressive symptoms predict falls after stroke. Stroke 33:542-547
23. Grey A 2008 Skeletal consequences of thiazolidinedione therapy. Osteoporos Int 19:129-137
24. Nickolas TL, Leonard MB, Shane E 2008 Chronic kidney disease and bone fracture: a growing concern. Kidney Int 74:721-731
25. Grey A, BollandM,Gamble G, Wattie D, Horne A, Davidson J, Reid IR 2007 The peroxisome proliferator-activated receptor-γ agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 92:1305-1310
26. Solomon DH, Cadarette SM, Choudhry NK, Canning C, Levin R, Stürmer T 2009 A cohort study of thiazolidinediones and fractures in older adults with diabetes. J Clin Endocrinol Metab 94:2792-2798
27. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M 2007 Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med 147: W163-W194
28. Deyo RA, Cherkin DC, Ciol MA 1992 Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619
29. Islam S, Liu Q, Chines A, Helzner E 2009 Trend in incidence of osteoporosis-related fractures among 40- to 69-year-old women: analysis of a large insurance claims database, 2000-2005. Menopause 16:77-83
30. 2004 SAS/STAT users guide, version 9.1. Cary, NC: SAS Institute Inc.
31. 2000 From the Food and Drug Administration. JAMA 283:2228
32. Watanabe S, Takeuchi Y, Fukumoto S, Fujita H, Nakano T, Fujita T 2003 Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients. J Bone Miner Metab 21:166-171
33. Rzonca SO, Suva LJ, Gaddy D, Montague DC, Lecka-Czernik B 2004 Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 145:401-406
34. Sorocéanu MA, Miao D, Bai XY, Su H, Goltzman D, Karaplis AC 2004 Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis. J Endocrinol 183:203-216
35. Spiegelman BM 1998 PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-514
36. Grey A 2009 Thiazolidinedione-induced skeletal fragility-mechanisms and implications. Diabetes Obes Metab 11:275-284
37. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H 2004 PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113:846-855
38. Wan Y, Chong LW, Evans RM 2007 PPAR-γ regulates osteoclastogenesis in mice. Nat Med 13:1496-1503
39. Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G 2008 Rosiglitazone- associated fractures in type 2 diabetes: an analysis from A Diabetes Outcome Progression Trial (ADOPT). Diabetes Care 31:845-851
40. Sottile V, Seuwen K, Kneissel M2004 Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARγ agonist BRL49653 (rosiglitazone). Calcif Tissue Int 75:329-337
41. Schwartz AV 2008 TZDs and bone: a review of the recent clinical evidence. PPAR Res 2008:297893
42. Douglas IJ, Evans SJ, Pocock S, Smeeth L 2009 The risk of fractures associated with thiazolidinediones: a self-controlled case-series study. PLoS Med 6:e1000154
43. Dormuth CR, Carney G, Carleton B, Bassett K, Wright JM 2009 Thiazolidinediones and fractures in men and women. Arch Intern Med 169:1395-1402
44. Whiteside GT, Boulet JM, Sellers R, Bunton TE, Walker K 2006 Neuropathy-induced osteopenia in rats is not due to a reduction in weight born on the affected limb. Bone 38:387-393
45. Williams LK, Joseph CL, Peterson EL, Wells K, Wang M, Chowdhry VK, Walsh M, Campbell J, R and CS, Apter AJ, Lanfear DE, Tunceli K, Pladevall M 2007 Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence. J Allergy Clin Immunol 120:1153-1159
46. Bishara SE, Cummins DM, Jorgensen GJ, Jakobsen JR 1995 A computer assisted photogrammetric analysis of soft tissue changes after orthodontic treatment. Part I: methodology and reliability. Am J Orthod Dentofacial Orthop 107:633-639